|
 |
Hematological malignanciesThis page contains recent news articles, when available, and an overview of Hematological malignancies but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.News: Hematological malignancies Free with registration - M2 Presswire - AccessMyLibrary.comThe markets segments for therapeutics for hematological malignancies are numerous and complicated. The historical general conception that relatively low ... Leukemia - NUP98 rearrangements in hematopoietic malignancies: a … - Feb 9, 2006 Nature.comKaryotypes of 71 patients with various hematological malignancies associated with a 11p15 chromosomal anomaly were reviewed during two workshops by the ... … EBV infections in patients with hematological malignancies and... - Dec 1, 2008 Nature.comA Joint Project of the European Organization for Research and Treatment of Cancer-Infectious Diseases Group, European Bone Marrow Transplantation-Infectious ... Randomized clinical trials for hematopoietic stem cell transplantation... - Nov 21, 2005 Nature.comA MEDLINE search was conducted to identify all published RCTs for the management of adult patients with hematological malignancies from January 1992 to ... … Review & Analysis Of Hematological Malignancies Report Available... - Apr 12, 2007 Pay-Per-View - M2 Presswire - HighBeam ResearchGlobal Pipeline Review & Analysis Of Hematological Malignancies Report Available Now! from M2 Presswire. Highbeam Research – FREE Trial. Hematological Malignancies: Companies Target Niche Indications to … - May 18, 2009 Pay-Per-View - M2 Presswire - HighBeam ResearchHematological Malignancies: Companies Target Niche Indications to Facilitate Market Entry. ... find M2 Presswire articles. M2 PRESSWIRE-18 May 2009-Research ... … : MarketResearch.com: "Pipeline Insight: Hematological malignancies... - May 5, 2005 Pay-Per-View - M2 Presswire - HighBeam ResearchMarketResearch.com: "Pipeline Insight: Hematological malignancies - Targeted treatments and immunotherapy infuse new blood" by Datamonitor May 2005. from M2 ... TP53 mutations in myeloid malignancies are either homozygous or … - Sep 17, 2009 Nature.comAlthough mutations in TP53 are frequent in solid tumors, the mutation frequency reported in hematological malignancies is much lower. 2 ... Genentech inks cancer research deal with GlycArt - Oct 3, 2008 Bizjournals.comHematological malignancies affect blood, bone marrow and lymph nodes. Genentech, Roche and GlycArt will share development costs, and Genentech will book ... Press Release: Hematological malignancies: evolving the lifeblood of ... - Jun 6, 2005 Pay-Per-View - M2 Presswire - HighBeam ResearchHematological malignancies: evolving the lifeblood of future pharmacotherapy. from M2 Presswire. Highbeam Research – FREE Trial. Press Release: Pipeline Insight - Hematological Malignancies … - Jun 22, 2009 Pay-Per-View - M2 Presswire - HighBeam ResearchPipeline Insight - Hematological Malignancies Companies target niche indications to facilitate market entry. from M2 Presswire. … Of Phase 1 Study Evaluating R763 In Hematological Malignancies - Feb 14, 2007 Medical News Today - Medical News Today (press release)R763 has shown encouraging results in in vitro and in vivo models of hematological malignancies where Aurora kinase is thought to play a role. ... Prophylactic infusion of donor granulocyte colony stimulating factor ... - Dec 3, 2005 Nature.comAdult patients with advanced hematological malignancies after allogeneic ... From May 2001 to March 2004, 24 patients with hematological malignancies who ... ASCO 2008: Highlights of Treatment of Hematological Malignancies - May 30, 2008 Cancer ConsultantsThe 2008 annual meeting of the American Society of Clinical Oncology, held in Chicago, Illinois, again revealed advances in the treatment of hematologic ... Lymphoma in a patient with systemic lupus erythematosus - Mar 17, 2006 Nature.comSome hematological malignancies can be associated with proteinuria (eg multiple myeloma). Multiple blood cultures are necessary to rule out bacteremia, ... … promise in lung cancer and hematological malignancies , but face... - May 7, 2007 Gerson Lehrman GroupXL-647 may be a promising agent for lung cancer and XL-518, a potent MEK inhibitor may have efficacy in hematological malignancies and several solid tumors. ... Press Release: Research and Markets: Hematological Malignancies - … - May 12, 2005 Pay-Per-View - PR Newswire - HighBeam ResearchResearch and Markets: Hematological Malignancies - Targeted Treatments and Immunotherapy Infuse New Blood. from PR Newswire. Highbeam Research – FREE Trial. Glycogen phosphorylase BB could be a new biomarker for detection of … - Nov 9, 2009 Nature.comThe aim of our present study was to assess cardiac toxicity during PR and HCT for various hematological malignancies using multiple biomarkers of cardiac ... … -5720 could reverse multidrug resistance in hematological malignanci... - Oct 17, 2006 Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones..."MDR due to over-expression of the MDR1 (ABCB1) gene and its Pgp product is an obstacle in the treatment of hematological malignancies. ... Research and Analysis of the Hematological Malignancies Pipeline. - May 21, 2007 $4.95 - M2 Presswire - ECNextM2 PRESSWIRE-21 May 2007-Research and Markets: Research and Analysis of the Hematological Malignancies Pipeline(C)1994-2007 M2 COMMUNICATIONS LTD Dublin ... Risk factors for invasive aspergillosis in neutropenic patients with ... - Feb 24, 2005 Nature.comSeveral risk factors for IA in patients with hematological malignancies have been ... Most patients cared for in this unit have hematological malignancies, ... ChemGenex, Hospira, Announce Agreement to License, Develop and … - Dec 13, 2009 Wall Street JournalOmacetaxine is a first-in-class cetaxine with demonstrated clinical activity as a single agent in a range of hematological malignancies. ... Research and Analysis of the Hematological Malignancies Pipeline - May 21, 2007 Genetic Engineering News - Genetic Engineering News (press release)Research and Markets (http://www.researchandmarkets.com/reports/c57404) has announced the addition of "Pipeline Insight: Hematological Malignancies ... Is BAL useful in patients with acute myeloid leukemia admitted in ICU... - Apr 24, 2008 Nature.com6,9 The rate of FOB-BAL-related complications is usually acceptable in patients with hematological malignancies (HM) without ARF. ... PASD1, a DLBCL-associated cancer testis antigen and candidate for … - Oct 5, 2006 Nature.comThis is the first detailed report of the protein expression of the novel PASD1 antigen in normal tissues and a range of hematological malignancies. ... Pipeline Insight: Hematological Malignancies - Targeted Treatments... - Apr 20, 2005 MarketResearch.comGiven an enhanced understanding of the biological basis for oncogenesis and the benefit of immunotherapy approaches such as Genentech/Roche's Rituxan, ... Anemia Management for Patients with Lymphoid Malignancies - Jan 4, 2008 National Anemia Action Council...and the survey also reported that fatigue was the most frequent and long-lasting symptom in patients with hematological malignancies. ... Induction of CD45 expression on bone marrow-derived mesenchymal … - Mar 9, 2006 Nature.comAs the MSCs used in the current study were isolated from different patients of hematological malignancies and at different passages of ex vivo expansion, ... Deciding intensive care unit-admission for critically ill cancer... - Jan 1, 2007 Free with registration - Indian Journal of Critical Care Medicine - AccessMyLibrary.comIn a series of patients with hematological malignancies, Massion et al , evaluated the ICU and in-hospital prognosis according to the patient's long term ... Cellerant starts Phase I study of CLT-008 for hematological malignanci... - May 13, 2009 $9.94 - M2 Europharma - Alacra StoreCellerant starts Phase I study of CLT-008 for hematological malignancies. M2 EUROPHARMA-(C)1999-2009 M2 COMMUNICATIONS LTD ... SuperGen's PIM Kinase Inhibitor, SGI-1776, Causes Tumor Regression in... - Jun 13, 2008 RedOrbit...pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, ... Hematological malignancies: evolving the lifeblood of future … - Jun 6, 2005 $4.95 - M2 Presswire - ECNextLondon - Hailed as a beacon for the future of cancer drug development when it was launched in May 2001, Novartis' Glivec has achieved a dominant position in ... Onyx Pharmaceuticals Completes Acquisition of Proteolix, Inc. - Nov 16, 2009 MarketWatch...focused on discovering and developing novel therapies that target the proteasome for the treatment of hematological malignancies and solid tumors. ... Fludarabine/iv BU conditioning regimen: myeloablative, reduced... - Feb 11, 2008 Nature.comThe treatment of hematological malignancies, which are considered at high risk ... 6 In patients with hematological malignancies at high risk of relapse, ... A retrospective study of 69 patients with t(6;9)(p23;q34) AML... - Apr 20, 2006 Nature.comThe World Health Organization classification of hematological malignancies report of the clinical advisory committee meeting, Airlie House, Virginia, ... Hematological malignancies: evolving the lifeblood of future … - Jun 10, 2005 Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow JonesHailed as a beacon for the future of cancer drug development when it was launched in May 2001, Novartis's Glivec has achieved a dominant position in the ... Serenex Announces Initiation of Second Phase 1 Trial for Oral Hsp90 … - Dec 4, 2007 marketwire.comThe phase 1 study will be a dose escalation trial involving up to 50 patients with hematological malignancies. The trial will evaluate safety, ... Onyx Pharmaceuticals to Acquire Proteolix, Inc. - Oct 12, 2009 Stockhouse...focused on discovering and developing novel therapies that target the proteasome for the treatment of hematological malignancies and solid tumors. ... Reduced-intensity conditioning using fludarabine with either … - Sep 5, 2008 Nature.comPatients with hematological malignancies (n=66) who were referred to the Shands-University of Florida Bone Marrow Transplant Program were considered for ... … in HSCT offers better treatments for hematological malignancies - Feb 6, 2005 Pay-Per-View - Medical Devices & Surgical Technology... - Factiva, from Dow Jones2005 FEB 6 - (NewsRx.com & NewsRx.net) -- Advances in allogeneic hematopoietic cell transplantation offers better treatments for hematological malignancies. ... Fludarabine phosphate and melphalan: a reduced intensity conditioning... - Jan 23, 2006 Nature.comFludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell ... HLA-mismatched hematopoietic SCT without in vitro T-cell depletion... - Jan 11, 2010 Nature.comHaploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. ... Rescue from failed growth factor and/or chemotherapy HSC mobilization... - Feb 2, 2009 Nature.comCorrespondence: Dr RT Maziarz, Center for Hematological Malignancies, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Mailcode UHN73C, ... Research and Analysis of the Hematological Malignancies Pipeline. - May 21, 2007 Free with registration - Business Wire - AccessMyLibrary.com180 different pipeline candidates have been identified of which 22 are in late-phase development. These existing candidates have a forecast sales potential ... … in HSCT offers better treatments for hematological malignancies - Feb 2, 2005 Pay-Per-View - Immunotherapy Weekly - Factiva, from Dow Jones2005 FEB 2 - (NewsRx.com & NewsRx.net) -- Advances in allogeneic hematopoietic cell transplantation offers better treatments for hematological malignancies. ... Keratinocyte growth factor is effective in the prevention of intestina... - Jun 16, 2008 Nature.comHematopoietic SCT (HSCT) is a potentially curative therapeutic procedure for patients with relapsed or refractory hematological malignancies. ... 454 Sequencing Systems and NimbleGen Sequence Capture Show … - Dec 9, 2009 Wall Street Journal..."We identified 454 Sequencing technology as a promising method to characterize leukemia and other hematological malignancies. In our research on a variety ... … Myeloma and Other Hematological Malignancies to Be Presented at... - Dec 7, 2006 $4.95 - PR Newswire - ECNextBOULDER, Colo., Dec. 7 /PRNewswire-FirstCall/ -- Pharmion Corporation reported today that data from several studies of thalidomide, including one that will ... … in HSCT offers better treatments for hematological malignancies - Feb 3, 2005 Pay-Per-View - Blood Weekly - Factiva, from Dow Jones2005 FEB 3 - (NewsRx.com & NewsRx.net) -- Advances in allogeneic hematopoietic cell transplantation offers better treatments for hematological malignancies. ... Non-myeloablative stem cell transplantation in patients with relapsed... - Jul 9, 2007 Nature.comHematopoietic cell transplantation in older patients with hematological malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effect. ... Cytogenetic profile of de novo acute myeloid leukemia: a study based... - May 28, 2009 Nature.comRacial differences in various hematological malignancies were previously reported between Asian and western countries. However, no systematic study has been ... A prospective study to evaluate a new dental management protocol … - Feb 13, 2006 Nature.comOf 71 patients with hematological malignancies, 41 underwent HSCT therapy; 30 did not because their general condition was poor or because no appropriate ... MarketResearch.com: "Pipeline Insight: Hematological malignancies - … - May 5, 2005 $4.95 - M2 Presswire - ECNext...on STIs offers developers the potential to target drivers of oncogenesis that may exhibit commonality across a spectrum of hematological malignancies. ... A pilot study of low-dose recombinant interleukin-2 for acute … - Jul 21, 2008 Nature.comAllogeneic hematopoietic stem cell transplantation (allo-HSCT) is the most effective therapeutic approach for many hematological malignancies. ... Hypermethylation of TTC12 gene in acute lymphoblastic leukemia - Jul 26, 2007 Nature.comMonni O, Knuutila S. 11q deletions in hematological malignancies. Leuk Lymphoma 2001; 40: 259–266. | PubMed | ISI | ChemPort | ... … ; When patients with hematological malignancies develop GI problems,... - Jun 21, 2005 Pay-Per-View - Life Science Weekly - Factiva, from Dow JonesThe researchers concluded: "Thus, in patients with hematological malignancies who develop significant gastrointestinal symptoms, we recommend that ... Michael Baker Corp acquires Buck Engineering PC - Deal Snapshot - … - Apr 6, 2006 Pay-Per-View - deals - Alacra StoreProduct Status SGN - ## PC Hematological Malignancies Clinical trial initiation…## SGN - ## Hematological Malignancies PC ## SGN - ## / SGN - ##… ... Unrelated cord blood transplantation after myeloablative conditioning... - Oct 27, 2008 Nature.com...of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematological malignancies. Blood 2004; 104: 3813–3820. ... Research and Markets: Hematological Malignancies - Targeted … - May 12, 2005 $4.95 - PR Newswire - ECNextDUBLIN, Ireland, May 12 /PRNewswire/ -- Research and Markets (http://www. researchandmarkets.com/reports/c17352 ) has announced the addition of Hematological ... Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and ... - Aug 17, 2007 Free with registration - PR Newswire - AccessMyLibrary.com...rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that Audrey F. Jakubowski, Ph.D., ... Patient and family education in HSCT: improving awareness of respirato... - Aug 17, 2009 Nature.com...other hematological malignancies (39 out of 122, 32%); non-malignant hematological diseases (17 out of 122, 14%); and non-hematological malignancies (2 ... Impact of comorbidity indexes on non-relapse mortality - Aug 7, 2008 Nature.comAllogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative procedure for many patients with hematological malignancies and some ... … ; When patients with hematological malignancies develop GI problems,... - Jun 20, 2005 Pay-Per-View - Gastroenterology Week - Factiva, from Dow JonesThe researchers concluded: "Thus, in patients with hematological malignancies who develop significant gastrointestinal symptoms, we recommend that ... … and fludarabine are well-tolerated in hematological malignancies - Feb 14, 2005 Pay-Per-View - Hematology Week - Factiva, from Dow JonesThiotepa plus fludarabine conditioning regimen followed by allogeneic blood stem cell transplantation for hematological malignancies is well-tolerated. ... Compound heterozygosity for two MSH6 mutations in a patient with... - Aug 15, 2005 Nature.comBiallelic mutations in these genes have been reported for a limited number of cases resulting in hematological malignancies, brain tumors and ... Loss of antibodies and response to (re-)vaccination in children after... - Aug 3, 2006 Nature.comHamarstrom V, Pauksen K, Svensson H, Oberg G, Paul C, Ljungman P. Tetanus immunity in patients with hematological malignancies. Support Care Cancer 1998; ... SuperGen's CLIMB technology identifies lead Pim kinase inhibitors - Dec 10, 2007 News-Medical.netEntitled "Targeting Pim Kinases in Hematological Malignancies," the poster described how scientists used SuperGen's CLIMB(TM) technology to build a model to ... CureTech Announces Encouraging Phase I Clinical Trial Results in … - Apr 11, 2005 RedOrbitThe safety profile of CT-011 was evaluated in 17 patients suffering from advanced-stage hematological malignancies. CT-011 was given in a single 5h IV ... A simplified method for stem cell autografting in multiple myeloma: a... - Apr 6, 2009 Nature.comIn addition, unlike with other hematological malignancies relapsing after an auto SCT, recurrent disease can be treated with novel agents or repeat ... … Phase II Study Of Darinaparsin In Advanced Hematological Malignanci... - Apr 18, 2008 Medical News Today - Medical News Today (press release)A total of 40 patients with a variety of hematological malignancies, including leukemias ... Further study of darinaparsin in hematological malignancies, ... Phase I Trial of Rigel' Aurora Kinase Inhibitor Begins - Feb 15, 2007 Cancer FocusThe trials will tests the inhibitor in solid tumors, hematological malignancies, and in combination with standard therapies. ... International Immunocompromized Host Society conference reviewed.( … - Aug 21, 2006 Free with registration - Pharma Marketletter - AccessMyLibrary.com...and people with leukemia and other hematological malignancies where effective antifungal therapy has become an essential part of their management. ... … Phase II Study of Darinaparsin in Advanced Hematological Malignanci... - Apr 16, 2008 Genetic Engineering News - Genetic Engineering News (press release)A total of 40 patients with a variety of hematological malignancies, including leukemias ... Further study of darinaparsin in hematological malignancies, ... ZIOPHARM Oncology to Present at the Biotech ShowcaseTM, San … - Jan 6, 2010 Wall Street JournalPhase I trials with the oral form are ongoing in both hematological malignancies and solid tumors. Indibulin (ZybulinTM or ZIO-301) is a novel, oral tubulin ... Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on ... - Mar 23, 2009 Nature.comThe study population comprised 107 consecutive patients with hematological malignancies from a single medical center with IPA diagnosed between 1998 and ... TopoTarget A/S acquires G2M Cancer Drugs AG - Deal Snapshot - … - Mar 1, 2005 Pay-Per-View - deals - Alacra StoreTOPOTARGET A/S-COMPANY INSIGHT · TOPOTARGET A/S-COMPANY INSIGHT, Life Science Analytics, Aug 13 2008, $2320.00 …hematological malignancies. ... PI-PLC-1 and activated Akt levels are linked to azacitidine … - Jul 12, 2007 Nature.com1 The involvement of PI-PLC-1 in hematopoietic differentiation prompted us to investigate the role of this signaling molecule in hematological malignancies, ... Reply to 'Lack of association of the heparanase gene single-nucleotide... - Feb 28, 2008 Nature.comIn our second study, 2 we investigated the association of HPSE gene SNPs with hematological malignancies. In this study, our patients group was ... Tumor cell contamination in ovarian tissue cryopreserved before … - Nov 16, 2009 Nature.comMinimal residual disease (MRD) monitoring is currently used extensively in hematological malignancies and solid tumors and the question of MRD before OC ... Oncology; Hepatitis C genotypes are similar in patients with hemopoiet... - Apr 11, 2005 Pay-Per-View - Health & Medicine Week - Factiva, from Dow JonesKeywords: Moscow, Russia, Hematological Malignancies, Genotyping, Hepatitis C Virus, Virology, Leukemia, Lymphoma. This article was prepared by Health ... Oncology; Hepatitis C genotypes are similar in patients with hemopoiet... - Apr 14, 2005 Pay-Per-View - Blood Weekly - Factiva, from Dow JonesKeywords: Moscow, Russia, Hematological Malignancies, Genotyping, Hepatitis C Virus, Virology, Leukemia, Lymphoma. This article was prepared by Blood Weekly ... Oncology; Hepatitis C genotypes are similar in patients with hemopoiet... - Apr 11, 2005 Pay-Per-View - Hematology Week - Factiva, from Dow JonesKeywords: Moscow, Russia, Hematological Malignancies, Genotyping, Hepatitis C Virus, Virology, Leukemia, Lymphoma. This article was prepared by Hematology ... Oncology; Hepatitis C genotypes are similar in patients with hemopoiet... - Apr 16, 2005 Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow JonesKeywords: Moscow, Russia, Hematological Malignancies, Genotyping, Hepatitis C Virus, Virology, Leukemia, Lymphoma. This article was prepared by Obesity, ... Oncology; Hepatitis C genotypes are similar in patients with hemopoiet... - Apr 12, 2005 Pay-Per-View - Science Letter - Factiva, from Dow JonesKeywords: Moscow, Russia, Hematological Malignancies, Genotyping, Hepatitis C Virus, Virology, Leukemia, Lymphoma. This article was prepared by Science ... Oncology; Hepatitis C genotypes are similar in patients with hemopoiet... - Apr 11, 2005 Pay-Per-View - Hepatitis Weekly - Factiva, from Dow JonesKeywords: Moscow, Russia, Hematological Malignancies, Genotyping, Hepatitis C Virus, Virology, Leukemia, Lymphoma. This article was prepared by Hepatitis ... Oncology; Hepatitis C genotypes are similar in patients with hemopoiet... - Apr 12, 2005 Pay-Per-View - Virus Weekly - Factiva, from Dow JonesKeywords: Moscow, Russia, Hematological Malignancies, Genotyping, Hepatitis C Virus, Virology, Leukemia, Lymphoma. This article was prepared by Virus Weekly ... Oncology; Hepatitis C genotypes are similar in patients with hemopoiet... - Apr 12, 2005 Pay-Per-View - Cancer Weekly - Factiva, from Dow JonesKeywords: Moscow, Russia, Hematological Malignancies, Genotyping, Hepatitis C Virus, Virology, Leukemia, Lymphoma. This article was prepared by Cancer ... Leukemia; Reports from the United States, India and Australia add new... - May 15, 2006 Pay-Per-View - Cancer Weekly - Factiva, from Dow JonesStudy 3: When patients with hematological malignancies develop significant gastrointestinal (GI) symptoms, endoscopic investigations and biopsies should be ... Expression of heat-shock protein-90 in non-Hodgkin's lymphomas - Jul 15, 2005 Nature.comRecently, in vitro studies have shown that treatment of solid tumors and hematological malignancies with a naturally occurring antibiotic, geldanamycin, ... Diagnosis of occult tuberculosis in hematological malignancy by … - Dec 15, 2005 Nature.comHowever, the TST is of little help in immunosuppressed patients, such as those with hematological malignancies, who often have falsely negative TST results. ... Relationship between tacrolimus blood concentrations and clinical … - Nov 16, 2009 Nature.comA total of 97 pediatric patients with hematological malignancies met the study criteria. On the ROC, a cutoff of 7 ng/ml provided the best balance between ... Levels of soluble CD137 are enhanced in sera of leukemia and … - Mar 3, 2005 Nature.comThe sera of 173 patients with different hematological malignancies had significantly higher sCD137 concentrations. The mean and maximum sCD137 ... A microRNA cluster as a target of genomic amplification in malignant ... - Sep 15, 2005 Nature.comAbnormal miRNA expression of hematological malignancies has recently been reported. For example, the miR-155 precursor is enriched in Burkitt's lymphoma ... A novel NUP98-PHF23 fusion resulting from a cryptic translocation... - Feb 8, 2007 Nature.comChromosome translocations are recurrent features of various hematological malignancies. The cloning of the translocation breakpoints has led to the ... Somatic and germline genetics at the JAK2 locus - Apr 1, 2009 Nature.comMyeloproliferative neoplasms are hematological malignancies frequently associated with somatically acquired mutation of the JAK2 gene. ... 'FISH is at the forefront of molecular diagnostics and molecular … - Mar 15, 2005 Express Healthcare ManagementOur laboratory has developed and established more than 30 different molecular cytogenetics tests in hematological malignancies, pediatric malignancies like ... Performing allogeneic and autologous hematopoietic SCT in the … - Nov 30, 2009 Nature.comHome care vs hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia. Ann Oncol 2005; 16: 195–205. ... The expression levels of the pro-apoptotic XAF-1 gene modulate the … - Oct 22, 2009 Nature.comSecchiero P, di Iasio MG, Gonelli A, Zauli G. The MDM2 inhibitors Nutlins as an innovative therapeutic tool for the treatment of hematological malignancies. ... Efficacy of caspofungin as secondary prophylaxis in patients undergoin... - May 28, 2007 Nature.comEighteen patients affected by hematological malignancies and a previous IFI were submitted to allogeneic stem cell transplantation, using Caspofungin as a ... Allo-SCT using reduced-intensity conditioning against advanced … - Apr 7, 2008 Nature.com...advantage over conventional chemotherapy, some studies have suggested that RICT may be beneficial in elderly patients with hematological malignancies. 2 ... Background information on Hematological malignancies [When available] Although hematological malignancies are a form of cancer, they are generally treated by specialists in hematology, although in many hospitals oncology specialists also manage these diseases. ("Hematology/Oncology" is a single subspecialty of Internal Medicine; there are also surgical and radiation oncologists.) Hematological malignancies are the types of cancer that affect blood, bone marrow and lymph nodes. As the three are intimately connected through the immune system, a disease affecting one of the three will often affect the others as well: although lymphoma is technically a disease of the lymph nodes, it often spreads to the bone marrow, affecting the blood and occasionally producing a paraprotein. Chromosomal translocations are a common cause of these diseases, while this is uncommon in solid tumors. This leads to a different approach in diagnosis and treatment of hematological malignancies. Search the web for more resources on Hematological malignancies |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
